blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2330420

EP2330420 - DIAGNOSIS METHOD AND DIAGNOSIS KIT FOR CLINICAL AMYOPATHIC DERMATOMYOSITIS [Right-click to bookmark this link]
Former [2011/23]DIAGNOSIS METHOD AND DIAGNOSIS KIT FOR DERMATOMYOSITIS
[2014/04]
StatusNo opposition filed within time limit
Status updated on  13.07.2018
Database last updated on 24.04.2024
FormerThe patent has been granted
Status updated on  04.08.2017
FormerGrant of patent is intended
Status updated on  05.04.2017
FormerExamination is in progress
Status updated on  11.11.2016
Most recent event   Tooltip03.07.2020Lapse of the patent in a contracting state
New state(s): CY, MK		published on 05.08.2020  [2020/32]
Applicant(s)For all designated states
Keio University
15-45 Mita 2-chome Minato-ku
Tokyo 108-8345 / JP
[2011/23]
Inventor(s)01 / KUWANA, Masataka
c/o School of Medicine
Keio University
35 Shinanomachi
Shinjuku-ku
Tokyo 160-8582 / JP
02 / SATO, Shinji
c/o School of Medicine
Keio University
35 Shinanomachi
Shinjuku-ku
Tokyo 160-8582 / JP
03 / FUJITA, Takashi
c/o Institute for Virus Research
Kyoto University
53 Shogoin-kawaharacho
Sakyo-ku
Kyoto-shi Kyoto 606-8507 / JP
 [2017/36]
Former [2011/23]01 / KUWANA, Masataka
c/o School of Medicine Keio University 35 Shinanomachi Shinjuku-ku
Tokyo 160-8582 / JP
02 / SATO, Shinji
c/o School of Medicine Keio University 35 Shinanomachi Shinjuku-ku
Tokyo 160-8582 / JP
03 / FUJITA, Takashi
c/o Institute for Virus Research Kyoto University 53 Shogoin-kawaharacho Sakyo-ku
Kyoto-shi Kyoto 606-8507 / JP
Representative(s)Müller-Boré & Partner Patentanwälte PartG mbB
Friedenheimer Brücke 21
80639 München / DE
[2017/36]
Former [2011/23]Müller-Boré & Partner Patentanwälte
Grafinger Straße 2
81671 München / DE
Application number, filing date09809743.931.07.2009
[2011/23]
WO2009JP63633
Priority number, dateJP2008022378901.09.2008         Original published format: JP 2008223789
[2011/23]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010024089
Date:04.03.2010
Language:JA
[2010/09]
Type: A1 Application with search report 
No.:EP2330420
Date:08.06.2011
Language:EN
[2011/23]
Type: B1 Patent specification 
No.:EP2330420
Date:06.09.2017
Language:EN
[2017/36]
Search report(s)International search report - published on:JP04.03.2010
(Supplementary) European search report - dispatched on:EP04.08.2011
ClassificationIPC:G01N33/564, G01N33/68, G01N33/53
[2017/14]
CPC:
G01N33/5743 (EP,US); G01N33/6854 (EP,US)
Former IPC [2012/32]G01N33/53, G01N33/68, G01N33/574
Former IPC [2011/36]G01N33/53, G01N33/68
Former IPC [2011/23]G01N33/53
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2017/36]
Former [2011/23]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  SM,  TR 
Extension statesALNot yet paid
BANot yet paid
RSNot yet paid
TitleGerman:DIAGNOSEVERFAHREN UND DIAGNOSEKIT FÜR KLINISCHE AMYOPATHISCHE DERMATOMYOSITIS[2014/04]
English:DIAGNOSIS METHOD AND DIAGNOSIS KIT FOR CLINICAL AMYOPATHIC DERMATOMYOSITIS[2014/04]
French:PROCÉDÉ DE DIAGNOSTIC ET KIT DE DIAGNOSTIC POUR LA DERMATOMYOSITE AMYOPATHIQUE CLINIQUE[2014/04]
Former [2011/23]DIAGNOSEVERFAHREN UND DIAGNOSEKIT FÜR DERMATOMYOSITIS
Former [2011/23]DIAGNOSIS METHOD AND DIAGNOSIS KIT FOR DERMATOMYOSITIS
Former [2011/23]PROCÉDÉ DE DIAGNOSTIC ET KIT DE DIAGNOSTIC POUR LA DERMATOMYOSITE
Entry into regional phase16.03.2011Translation filed 
24.03.2011National basic fee paid 
24.03.2011Search fee paid 
24.03.2011Designation fee(s) paid 
24.03.2011Examination fee paid 
Examination procedure16.12.2009Request for preliminary examination filed
International Preliminary Examining Authority: JP
24.03.2011Examination requested  [2011/23]
22.02.2012Amendment by applicant (claims and/or description)
19.09.2012Despatch of a communication from the examining division (Time limit: M06)
18.03.2013Reply to a communication from the examining division
08.01.2014Despatch of a communication from the examining division (Time limit: M04)
08.05.2014Reply to a communication from the examining division
07.08.2014Observations by third parties
18.03.2015Despatch of a communication from the examining division (Time limit: M06)
24.08.2015Reply to a communication from the examining division
11.09.2015Despatch of a communication from the examining division (Time limit: M04)
18.12.2015Reply to a communication from the examining division
08.01.2016Despatch of a communication from the examining division (Time limit: M06)
08.07.2016Reply to a communication from the examining division
25.07.2016Despatch of a communication from the examining division (Time limit: M04)
12.10.2016Reply to a communication from the examining division
03.11.2016Despatch of a communication from the examining division (Time limit: M04)
13.02.2017Reply to a communication from the examining division
06.04.2017Communication of intention to grant the patent
05.07.2017Receipt of the translation of the claim(s)
13.07.2017Fee for grant paid
13.07.2017Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  19.09.2012
Opposition(s)07.06.2018No opposition filed within time limit [2018/33]
Fees paidRenewal fee
28.07.2011Renewal fee patent year 03
30.07.2012Renewal fee patent year 04
31.07.2013Renewal fee patent year 05
30.07.2014Renewal fee patent year 06
28.07.2015Renewal fee patent year 07
27.07.2016Renewal fee patent year 08
25.07.2017Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU31.07.2009
AT06.09.2017
CY06.09.2017
CZ06.09.2017
DK06.09.2017
EE06.09.2017
ES06.09.2017
FI06.09.2017
HR06.09.2017
IT06.09.2017
LT06.09.2017
LV06.09.2017
MC06.09.2017
MK06.09.2017
NL06.09.2017
PL06.09.2017
PT06.09.2017
RO06.09.2017
SE06.09.2017
SI06.09.2017
SK06.09.2017
SM06.09.2017
TR06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
IS06.01.2018
[2020/31]
Former [2020/27]HU31.07.2009
AT06.09.2017
CZ06.09.2017
DK06.09.2017
EE06.09.2017
ES06.09.2017
FI06.09.2017
HR06.09.2017
IT06.09.2017
LT06.09.2017
LV06.09.2017
MC06.09.2017
NL06.09.2017
PL06.09.2017
PT06.09.2017
RO06.09.2017
SE06.09.2017
SI06.09.2017
SK06.09.2017
SM06.09.2017
TR06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
IS06.01.2018
Former [2020/16]AT06.09.2017
CZ06.09.2017
DK06.09.2017
EE06.09.2017
ES06.09.2017
FI06.09.2017
HR06.09.2017
IT06.09.2017
LT06.09.2017
LV06.09.2017
MC06.09.2017
NL06.09.2017
PL06.09.2017
RO06.09.2017
SE06.09.2017
SI06.09.2017
SK06.09.2017
SM06.09.2017
TR06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
IS06.01.2018
Former [2019/15]AT06.09.2017
CZ06.09.2017
DK06.09.2017
EE06.09.2017
ES06.09.2017
FI06.09.2017
HR06.09.2017
IT06.09.2017
LT06.09.2017
LV06.09.2017
MC06.09.2017
NL06.09.2017
PL06.09.2017
RO06.09.2017
SE06.09.2017
SI06.09.2017
SK06.09.2017
SM06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
IS06.01.2018
Former [2018/39]AT06.09.2017
CZ06.09.2017
DK06.09.2017
EE06.09.2017
ES06.09.2017
FI06.09.2017
HR06.09.2017
IT06.09.2017
LT06.09.2017
LV06.09.2017
NL06.09.2017
PL06.09.2017
RO06.09.2017
SE06.09.2017
SI06.09.2017
SK06.09.2017
SM06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
IS06.01.2018
Former [2018/35]AT06.09.2017
CZ06.09.2017
DK06.09.2017
EE06.09.2017
ES06.09.2017
FI06.09.2017
HR06.09.2017
IT06.09.2017
LT06.09.2017
LV06.09.2017
NL06.09.2017
PL06.09.2017
RO06.09.2017
SE06.09.2017
SK06.09.2017
SM06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
IS06.01.2018
Former [2018/24]AT06.09.2017
CZ06.09.2017
EE06.09.2017
ES06.09.2017
FI06.09.2017
HR06.09.2017
IT06.09.2017
LT06.09.2017
LV06.09.2017
NL06.09.2017
PL06.09.2017
RO06.09.2017
SE06.09.2017
SK06.09.2017
SM06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
IS06.01.2018
Former [2018/23]AT06.09.2017
CZ06.09.2017
EE06.09.2017
ES06.09.2017
FI06.09.2017
HR06.09.2017
LT06.09.2017
LV06.09.2017
NL06.09.2017
PL06.09.2017
RO06.09.2017
SE06.09.2017
SK06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
IS06.01.2018
Former [2018/21]CZ06.09.2017
ES06.09.2017
FI06.09.2017
HR06.09.2017
LT06.09.2017
LV06.09.2017
NL06.09.2017
SE06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
Former [2018/15]ES06.09.2017
FI06.09.2017
HR06.09.2017
LT06.09.2017
LV06.09.2017
NL06.09.2017
SE06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
Former [2018/12]ES06.09.2017
FI06.09.2017
HR06.09.2017
LT06.09.2017
LV06.09.2017
SE06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
Former [2018/10]FI06.09.2017
HR06.09.2017
LT06.09.2017
SE06.09.2017
NO06.12.2017
Former [2018/09]FI06.09.2017
LT06.09.2017
SE06.09.2017
NO06.12.2017
Former [2018/08]FI06.09.2017
LT06.09.2017
NO06.12.2017
Former [2018/07]LT06.09.2017
NO06.12.2017
Documents cited:Search[A]US6160107  (TARGOFF IRA N [US], et al) [A] 1-10 * column 6, line 36 - line 46; figures 1-4; claims 1-8 *;
 [T]  - SHINJI SATO ET AL, "RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease", ARTHRITIS & RHEUMATISM, (20090701), vol. 60, no. 7, doi:10.1002/art.24621, ISSN 0004-3591, pages 2193 - 2200, XP055003397 [T] 1-10 * page 2199, column 1, paragraph 4 - page 2199, column 2, paragraph 1 *

DOI:   http://dx.doi.org/10.1002/art.24621
International search[A]  - SATO S ET AL., ARTHRITIS RHEUM., (200505), vol. 52, no. 5, pages 1571 - 1576, XP055003396

DOI:   http://dx.doi.org/10.1002/art.21023
 [A]  - MICHITO HIRAKATA, JAPANESE JOURNAL OF CHINICAL IMMUNOLOGY, (2007), vol. 30, no. 6, pages 444 - 454, XP008144413
 [A]  - SHINJI SATO, MOLECULAR RHEUMATOLOGY, (2006), vol. 3, no. 1, pages 3 - 8, XP008144818
 [A]  - YAMASAKI Y ET AL., ARTHRITIS RHEUM., (200702), vol. 56, no. 2, pages 596 - 604, XP008144817
 [A]  - VILLERS A ET AL., ANN DERMATOL VENEREOL., (200607), vol. 133, no. 6-7, pages 573 - 576, XP008144394
ExaminationWO2005016962
    - YOSHIRO HORAI ET AL, "Early diagnosis and treatment for remission of clinically amyopathic dermatomyositis complicated by rapid progress interstitial lung disease: a report of two cases", MODERN RHEUMATOLOGY ; OFFICIAL JOURNAL OF THE JAPAN COLLEGE OF RHEUMATOLOGY, SPRINGER-VERLAG, TO, Spinger Inc Tokyo, (20120330), vol. 23, no. 1, doi:10.1007/S10165-012-0637-6, ISSN 1439-7609, pages 190 - 194, XP035162400

DOI:   http://dx.doi.org/10.1007/s10165-012-0637-6
    - M. J. FRITZLER ET AL, "Molecular characterization of two human autoantigens: unique cDNAs encoding 95- and 160-kD proteins of a putative family in the Golgi complex", JOURNAL OF EXPERIMENTAL MEDICINE, Rockefeller University Press, New York NY USA, (19930701), vol. 178, no. 1, doi:10.1084/jem.178.1.49, ISSN 0022-1007, pages 49 - 62, XP055176177

DOI:   http://dx.doi.org/10.1084/jem.178.1.49
    - H. KATO ET AL, "Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses", NATURE, Basingstoke UK, (20060409), vol. 441, no. 7089, doi:10.1038/nature04734, ISSN 0028-0836, pages 101 - 105, XP055094652

DOI:   http://dx.doi.org/10.1038/nature04734
    - S. MOGHADAM-KIA ET AL., "Anti-Melanoma Differentiation-Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis", ARTHRITIS CARE & RESEARCH, Hoboken NJ USA, (20160501), vol. 68, no. 5, pages 689 - 694
    - D-TEK, MDA-5, Mons BE, D-TEK, (20151001), pages 1 - 2, XP055289407
    - MOISES LABRADOR-HORILLO ET AL, "Anti-MDA5 Antibodies in a Large Mediterranean Population of Adults with Dermatomyositis", JOURNAL OF IMMUNOLOGY RESEARCH, Cairo, (20140204), vol. 2014, pages 1 - 8, XP055289406

DOI:   http://dx.doi.org/10.1155/2014/290797
other   - FRITZLER M.J.ET AL, "MOLECULAR CHARACTERIZATION OF TWO HUMAN AUTOANTIGENS: UNIQUE CDNAS ENCODING 95- AND 160-KD PROTEINS OF A PUTATIVE FAMILY IN THE GOLGI COMPLEX", JOURNAL OF EXPERIMENTAL MEDICINE, (19930701), vol. 178, no. 1, pages 49 - 62, XP055176177

DOI:   http://dx.doi.org/10.1084/jem.178.1.49
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.